03:22 PM EST - MedReleaf Corp. : Announced financial and operating results for the third quarter fiscal 2018 ending December 31, 2017. The company reported record sales of $11.4 million, an increase of 9% from the prior year period, and a 16% increase from the second quarter of fiscal 2018. Adjusted EBITDA loss of $0.2 million, a decrease of $4.3 million from the prior year period. MedReleaf Corp.
shares T.LEAF are trading up $1.22 at $19.76.
